Semaglutide, sold as Wegovy and Ozempic, may reduce opioid overdoses in people with opioid-use disorder and type 2 diabetes.

In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Weight loss drugs are rising in popularity. Savannah doctors weigh in on risks and benefits ...

Grammy winner Lizzo shared a vulnerable video detailing a difficult day in her weight loss journey and reminded her followers ...

In this article, we will discuss: 12 Best Growth Stocks To Buy According To Hedge Funds.

WeightWatchers announced the departure of CEO Sima Sistani, effective immediately, and board member Tara Comonte, former ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...